Callitas Theraputics Inc., a wholly owned subsidiary of Callitas Health Inc.

lthompson

About Lindsey Thompson

This author has not yet filled in any details.
So far Lindsey Thompson has created 3 blog entries.

Callitas Health Receives Confirmation from USPTO of Pending Patenting Status for CannaMint Strips

2017-11-15T21:34:21+00:00

CINCINNATI, OH, USA (November 9, 2017) – Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health and wellness, today announced that it has received confirmation from the United States Patent and Trademark Office (USPTO) of the pending patenting [...]

Callitas Health Receives Confirmation from USPTO of Pending Patenting Status for CannaMint Strips 2017-11-15T21:34:21+00:00

Callitas Health Announces Addition of Joshua Maurice to Strategic Management Team

2017-10-25T10:06:31+00:00

Cincinnati, OH, USA (FSCwire) - Callitas Health Inc. (CSE: LILY, OTCQB: MPHMD, FWB: T3F3), (the "Company" or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health and wellness, today announced that Joshua Maurice has joined the Callitas team as the Director of Sales and Marketing. Within this new role, Mr. Maurice [...]

Callitas Health Announces Addition of Joshua Maurice to Strategic Management Team 2017-10-25T10:06:31+00:00

Callitas Announces Positive FDA Response to Extrinsa Pre-IND Submission

2017-10-12T13:28:53+00:00

CINCINNATI, OH, USA (October 11, 2017) – Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health & wellness, today announced that with the assistance of Camargo Pharmaceutical Services (“Camargo”), it has received a successful response from the US [...]

Callitas Announces Positive FDA Response to Extrinsa Pre-IND Submission 2017-10-12T13:28:53+00:00